Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice.
Prompetchara E, Ketloy C, Alameh MG, Tharakhet K, Kaewpang P, Yostrerat N, Pitakpolrat P, Buranapraditkun S, Manopwisedjaroen S, Thitithanyanont A, Jongkaewwattana A, Hunsawong T, Im-Erbsin R, Reed M, Wijagkanalan W, Patarakul K, Techawiwattanaboon T, Palaga T, Lam K, Heyes J, Weissman D, Ruxrungtham K. Prompetchara E, et al. Among authors: wijagkanalan w. Nat Commun. 2023 Apr 21;14(1):2309. doi: 10.1038/s41467-023-37795-0. Nat Commun. 2023. PMID: 37085495 Free PMC article.
Safety and immunogenicity of a prefusion non-stabilized spike protein mRNA COVID-19 vaccine: a phase I trial.
Gatechompol S, Kittanamongkolchai W, Ketloy C, Prompetchara E, Thitithanyanont A, Jongkaewwattana A, Buranapraditkun S, Alameh MG, Ubolyam S, Sophonphan J, Apornpong T, Kerr S, Kamarulzaman A, Siwamogsatham S, Kroon E, Puthanakit T, Patarakul K, Palaga T, Wijagkanalan W, Carpenter A, Hong L, Weissman D, Ruxrungtham K; ChulaVAC-001 study team. Gatechompol S, et al. Among authors: wijagkanalan w. Nat Microbiol. 2022 Dec;7(12):1987-1995. doi: 10.1038/s41564-022-01271-0. Epub 2022 Nov 14. Nat Microbiol. 2022. PMID: 36376393 Clinical Trial.
Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study.
Puthanakit T, Prompetchara E, Gatechompol S, Ketloy C, Thitithanyanont A, Jongkaewwattana A, Buranapraditkun S, Ubolyam S, Kerr SJ, Sophonphan J, Apornpong T, Kittanamongkolchai W, Siwamogsatham S, Sriplienchan S, Patarakul K, Theerawit T, Promsena P, Nantanee R, Manomaisantiphap S, Chokyakorn S, Hong L, Samija M, Montefiori DC, Gao H, Eaton A, Wijagkanalan W, Alameh MG, Weissman D, Ruxrungtham K; ChulaVac001-Phase 2 study team. Puthanakit T, et al. Among authors: wijagkanalan w. Sci Rep. 2024 Jan 29;14(1):2373. doi: 10.1038/s41598-023-49653-6. Sci Rep. 2024. PMID: 38287068 Free PMC article. Clinical Trial.
Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: Real-world evidence.
Chaithongwongwatthana S, Wijagkanalan W, Wanlapakorn N, Fortuna L, Yuwaree V, Kerdsomboon C, Poredi IK, Mansouri S, Pham HT, Poovorawan Y. Chaithongwongwatthana S, et al. Among authors: wijagkanalan w. Int J Infect Dis. 2024 Apr 11;144:107047. doi: 10.1016/j.ijid.2024.107047. Online ahead of print. Int J Infect Dis. 2024. PMID: 38609035 Free article.
Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines.
Pitisuttithum P, Dhitavat J, Sirivichayakul C, Pitisuthitham A, Sabmee Y, Chinwangso P, Kerdsomboon C, Fortuna L, Spiegel J, Chauhan M, Poredi IK, van den Biggelaar AHJ, Wijagkanalan W, Viviani S, Mansouri S, Pham HT. Pitisuttithum P, et al. Among authors: wijagkanalan w. EClinicalMedicine. 2021 Jun 23;37:100976. doi: 10.1016/j.eclinm.2021.100976. eCollection 2021 Jul. EClinicalMedicine. 2021. PMID: 34386749 Free PMC article.
Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates.
Siriwattananon K, Manopwisedjaroen S, Shanmugaraj B, Rattanapisit K, Phumiamorn S, Sapsutthipas S, Trisiriwanich S, Prompetchara E, Ketloy C, Buranapraditkun S, Wijagkanalan W, Tharakhet K, Kaewpang P, Leetanasaksakul K, Kemthong T, Suttisan N, Malaivijitnond S, Ruxrungtham K, Thitithanyanont A, Phoolcharoen W. Siriwattananon K, et al. Among authors: wijagkanalan w. Front Plant Sci. 2021 May 13;12:682953. doi: 10.3389/fpls.2021.682953. eCollection 2021. Front Plant Sci. 2021. PMID: 34054909 Free PMC article.
DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice.
Prompetchara E, Ketloy C, Tharakhet K, Kaewpang P, Buranapraditkun S, Techawiwattanaboon T, Sathean-Anan-Kun S, Pitakpolrat P, Watcharaplueksadee S, Phumiamorn S, Wijagkanalan W, Patarakul K, Palaga T, Ruxrungtham K. Prompetchara E, et al. Among authors: wijagkanalan w. PLoS One. 2021 Mar 22;16(3):e0248007. doi: 10.1371/journal.pone.0248007. eCollection 2021. PLoS One. 2021. PMID: 33750975 Free PMC article.
Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adults in Thailand.
Fortuna L, Chaithongwongwatthana S, Soonthornworasiri N, Spiegel J, Wijagkanalan W, Mansouri S, van den Biggelaar AHJ, Pham HT. Fortuna L, et al. Among authors: wijagkanalan w. Vaccine. 2020 Dec 3;38(51):8194-8199. doi: 10.1016/j.vaccine.2020.10.070. Epub 2020 Nov 8. Vaccine. 2020. PMID: 33176935 Free article.
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial.
Chatzis O, Blanchard-Rohner G, Mondoulet L, Pelletier B, De Gea-Hominal A, Roux M, Huttner A, Hervé PL, Rohr M, Matthey A, Gutknecht G, Lemaître B, Hayem C, Pham HT, Wijagkanalan W, Lambert PH, Benhamou PH, Siegrist CA. Chatzis O, et al. Among authors: wijagkanalan w. Clin Microbiol Infect. 2021 Jun;27(6):878-885. doi: 10.1016/j.cmi.2020.08.033. Epub 2020 Sep 5. Clin Microbiol Infect. 2021. PMID: 32896653 Free article. Clinical Trial.
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
Blanchard Rohner G, Chatzis O, Chinwangso P, Rohr M, Grillet S, Salomon C, Lemaître B, Boonrak P, Lawpoolsri S, Clutterbuck E, Poredi IK, Wijagkanalan W, Spiegel J, Pham HT, Viviani S, Siegrist CA. Blanchard Rohner G, et al. Among authors: wijagkanalan w. Clin Infect Dis. 2019 Mar 19;68(7):1213-1222. doi: 10.1093/cid/ciy594. Clin Infect Dis. 2019. PMID: 30759183 Clinical Trial.
22 results